Chronic Pancreatitis

Gastroenterology
1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
2 programs
1
Creon36™Phase 21 trial
CREONN/A1 trial
Active Trials
NCT04949828Completed63Est. Feb 2024
NCT02849704Completed48Est. Nov 2017
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Ivacaftor 150 MGN/A1 trial
Active Trials
NCT07022327Active Not Recruiting1Est. Aug 2026
Precision BioSciences
1 program
Web-based CBTN/A1 trial
Active Trials
NCT03707431Completed90Est. Jul 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbVieCreon36™
Mission TherapeuticsIvacaftor 150 MG
AbbVieCREON
Precision BioSciencesWeb-based CBT

Clinical Trials (4)

Total enrollment: 202 patients across 4 trials

Fat Malabsorption in Chronic Pancreatitis

Start: Oct 2016Est. completion: Nov 201748 patients
Phase 2Completed

Ivacaftor Impact in an Adolescent Without a Cystic Fibrosis-Associated CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Mutation for Chronic Pancreatitis: Single-Patient Study Tracking Flare Frequency and Health Data Compared to Historical Records.

Start: May 2025Est. completion: Aug 20261 patients
N/AActive Not Recruiting

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms

Start: Sep 2021Est. completion: Feb 202463 patients
N/ACompleted

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis

Start: Apr 2019Est. completion: Jul 202490 patients
N/ACompleted

Related Jobs in Gastroenterology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space